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Purpose. The aim of this study was to determine ICF items indicating health problems for patients with a chronic
neurological disorder such as multiple sclerosis, Parkinson’s disease and neuromuscular disease.
Method. A Delphi study using three disease-specific panels composed of patients and proxies, medical and non-medical
health professionals (N¼ 98). Panels were asked to select items from the International Classification of Functioning,
Disability and Health (ICF) reflecting relevant disease-specific health problems. Items appraised as relevant by the panel
members were compared with items in established measures namely: the Minimal Record of Disability (MRD) and the
Disability and Impact Profile (DIP).
Results. Sixty-eight ICF items were considered to be the most relevant, and belonged to four ICF domains. No significant
differences were found between the appraisal of items by patients/proxies and health professionals. Agreement across the
disease panels appeared to be (very) strong. Differences between the three disease-specific panels were found for the ‘Body
Functions and Structures’ domain: consensus was reached by extension of the inclusion criteria. The ICF-item selection
covers almost all items of the established measures. The largest contrast was shown in the item selection for the
‘participation’ and ‘environmental factors’ domains.
Conclusions. Selected items indicate a broader scope in studying health problems compared with widely used health status
measures in neurology, especially for the ICF domains ‘Participation’ and ‘Environmental Factors’.
Keywords: ICF, International Classification of Functioning, disability and health, multiple sclerosis, Parkinson’s disease,
neuromuscular diseases, rehabilitation
Introduction
The definitive diagnosis of a chronic neurological
disease such as multiple sclerosis, Parkinson’s disease
or a neuromuscular disease has enormous conse-
quences on the health status and everyday func-
tioning of a person, such as performance of tasks,
participation in social life, housing, work and income.
Over the last two decades many health measures have
been developed and used in both clinical practice
and research. Some instruments are measures used
among patient groups with a different chronic disease,
for example the Disability and Impact Profile (DIP)
[1,2] applied in rehabilitation medicine; some mea-
sures are disease-specific, such as the Minimal
Record of Disability (MRD) [3] for Multiple Sclero-
sis; others are one-dimensional and purely function-
oriented such as the Barthel index [4], or have a
multidimensional structure covering ‘physical func-
tioning’, ‘psychological functioning’ and ‘social func-
tioning’, like Quality of Life instruments such as the
36-item Short Form Health Survey Questionnaire
(SF-36) [5], the 54-item Multiple Sclerosis Quality
of Life Scale (MSQoL-54) [6] or the 59-item
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Functional Assessment of Multiple Sclerosis Quality
of Life Questionnaire (FAMS-59) [7]. Due to the
prolific development and use of health measures there
are now ‘competing’ instruments in the area of
neurology demonstrating significant differences in
the contents of important domains of health-related
functioning. Moreover, there is no consensus on
how to measure these domains [8]. Furthermore,
comparisons across chronic diseases are problematic.
Consequently, it seems necessary to develop an
internationally accepted frame of reference in order
to define functioning, disability and health [8,9].
The International Classification of Function,
Disability and Health (ICF) of the World Health
Organization (WHO) [10] systematically describes
consequences of disease on functioning and health.
This classification covers almost all aspects of health,
which are systematically grouped in domains related
to ‘body functions and body structures’ (Body
Functions and Structures domain), ‘performance of
tasks’ (Activities domain), ‘involvement in life situa-
tions’ (Participation domain) as well as ‘factors with
an impact on all domains of functioning’ (Environ-
mental Factors). ICF-based measures may provide
support to overcome these comparison problems.
With about 1500 categories in its original form the
ICF is hardly practical and lacks feasibility. There-
fore, Stucki et al. [9,11] suggest defining short lists,
so-called Core Sets, of categories which are relevant
for specific conditions (e.g., stroke) or health care
situations (e.g., sub-acute care).
The main purposes of this study were (1) from the
complete set of ICF-items to select a representative
sample of health-related aspects appraised as relevant
and appropriate for patients with multiple sclerosis
(MS), Parkinson’s disease (PD) and neuromuscular
diseases (NMD) such as motor neuron diseases and
muscular dystrophies, and (2) to give an indication of
the content validity of the final set of included items.
Methods
At the start of the study it was obvious that a large
sample of experts would be needed to achieve
consensus on the (clinical) relevance of the final set
of selected items derived from the complete set of
ICF items. The (written) Delphi technique was used
since it is an efficient means of combining the
expertise of a large, geographically dispersed group
of experts [12]. Experts were asked to complete two
assessment questionnaires. No face-to-face discus-
sions took place.
Panels
We organized the item selection among independent
panels for each of the diseases separately since it was
not clear whether significant differences would occur
in the selection of items between these diseases:
1. The multiple sclerosis subpanel.
2. The Parkinson’s disease subpanel.
3. The neuromuscular diseases subpanel.
Since we consider patients to be experts, at least one-
third of each disease subpanel should consist of
patients or proxies. Two-thirds of each subpanel
should consist of health professionals representing
relevant medical and non-medical disciplines. Con-
sequently, a large proportionate stratified sample
consisting of three strata was used:
1. Patients and proxies.
2. Medical professionals: neurologists, rehabili-
tation specialists, general practitioners, nur-
sing home doctors and nurse practitioners.
3. Non-medical health professionals: nurses and
nurse specialists, physiotherapists, occupatio-
nal therapists and social workers.
Patients and proxies were recruited among members
of the local and national patient associations. It was
assumed that their response reflected the associa-
tion’s collective framework of reference in order to
avoid information bias. Professionals were recruited
on the basis of their disease-specific expertise from
well-known specialized centres for neurological dis-
eases in The Netherlands and Belgium.
Potential panel members were approached by means
of a letter containing information about the goals,
methods and estimated required participation time,
followed by a telephone call in order to answer any
questions. After informed consent was received, the
questionnaire for the first assessment was then mailed.
Item selection
According to the ICF, items belonging to the
following categories were assessed by panel experts:
1. Body Functions and Structures: aspects of
body functions and body structure.
2. Activities: activities at the individual level.
3. Participation: aspects of participation in
society.
4. Environmental Factors: contextual aspects
with impact on the other three domains.
No item preselection was made to avoid selection
bias. Consequently, at baseline the experts in the
panels had to appraise each item from the complete
set of ICF items. The response options ranged from
‘not relevant’ (score 0), to ‘very relevant’ (score 4).
If panel members could not make up their minds
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about an assessment, they could answer with a
question mark. Respondents were instructed to fill
out the questionnaire with time intervals in order to
reduce bias through attrition and to optimise the
respondents’ compliance [12]. Body Functions and
Structures domain items were appraised only by the
‘medical professionals’ since assessment of these
items requires specific medical expertise.
Ordinal data was elaborated in order to detect
skewed distributions, outliers and items with extreme
outcomes on the central tendency measures. Criteria
[12] for inclusion of an ICF item in the initial sample
were:
1. An item appraised as ‘very relevant’ (median¼
score 4) by at least one disease subpanel.
2. An item appraised as ‘very relevant’ by the
stratum comprising ‘patients and proxies’
(median¼ score 4).
Although ICF items appraised by the complete panel
as ‘relevant’ (median¼ score 3) were valued as less
important, they were included in the initial sample in
order to test whether this criterion might lead to
erroneous item selection.
Items included in these initial samples of ‘very
relevant’ and ‘relevant’ items were presented to the
disease panels in the second assessment with the
request to ‘agree’ to include the items in the sample of
‘very relevant’ items in the final item selection, or to
‘agree’ with final rejection of items included in the
sample of ‘relevant’ items. The criterion for inclusion
of an item in the final selection was a score of 0.80 on
the content validity index [12], indicating a good
content validity across the expert ratings of each item’s
relevance: at least 80% of the complete panel had to
agree with an item’s inclusion in the item sample. In
cases where 80% of the experts agreed on inclusion of
an item in only one or two subpanels, while in the
overall sample less than 80% agreed on inclusion, the
investigators decided on final inclusion.
Interrater agreement
Although a general consensus was obtained in the
second assessment according to the inclusion criter-
ia, the assessment procedure did not allow the
calculation of obvious measures of interrater relia-
bility such as Cohen’s k [13].
Therefore, we suggest the interrater agreement
index D as a measure of dispersion, expressing the
mean of the absolute values of the deviations from






where Xi is the expert rating; N is the number of
experts; and M is the median.
The value by which we express the agreement
index (D) across the expert rating of each item’s
relevance has the advantage of easy interpretation.
In the current study, the ordinal scales have a range
from 0 to 4. A minimum D value of zero indicates
that the experts unanimously appraise an item as
relevant (each expert’s score¼ 3; median¼ 3) or
very relevant (each expert’s score¼ 4; median¼ 4).
When the sample of experts is not unanimously in
agreement with the appraisal of an item’s relevance,
the value of D is above zero. The maximum D
value only occurs in the unlikely situation that the
appraisal score of an item’s relevance is the extreme
opposite of the median. Since the sample of experts
in the current study was homogeneous, it seems
reasonable to expect a level of agreement between
0 and 1.
Convergent validity
To evaluate the content validity of the final sample of
items the selected items were compared with the
contents of two well-known valid and reliable meas-
ures: a disease-specific and a generic quality of life
measure. The items of these measures were linked to
the selected ICF items by two independent health
professionals with expertise in health-related func-
tional status measures as well as in both the ICF
content and neurological diseases. Experts were
asked to link each item belonging to the final sample
meticulously to the content of the corresponding
ICF item. Consensus on matched pairs of items
between the two health professionals was used to
decide to which ICF item the sample items should be
linked. To resolve disagreements between the two
health professionals, a third independent person with
the same expertise was consulted [14].
We used the Minimal Record of Disability (MRD)
for the disease-specific evaluation [3,15], also known
as the Minimal Data Set for Multiple Sclerosis. The
MRD is based on the first version of the ICF, namely
the ‘International Classification of Impairments,
Disabilities and Handicaps’ (ICIDH) [16 – 18]. The
MRD is based on three main domains:
1. The Impairment domain is reflected in the
observation based Functional Systems (FS)
scale and the overall Expanded Disability
Status Scale (E)DSS [19].
2. The Disabilities domain is reflected in the
self-report Incapacity Status Scale (ISS)
[20,21].
3. The Handicaps domain is reflected in the
self-report Environmental Status Scale (ESS)
[22].
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The subscales of the MRD are widely used in both
research and clinical practice and have satisfactory
psychometric properties [23 – 33].
The Disability and Impact Profile (DIP) [1,2,34]
was used for the generic quality of life evaluation in
rehabilitation. It is a self-report screening instrument
to assess disabilities, individually weighted with
respect to their relative importance or impact as
perceived by the rehabilitee. Although it has been
developed as a clinical instrument for the identifica-
tion of needs of individual patients, it is also used as
a population-specific rehabilitation Quality of Life
measurement. The DIP contains symptom ques-
tions and questions in five areas: mobility, self-care,




A total of 98 experts participated in the study: 37
were patients and proxies (38%) and 61 were health
professionals (62%) (Table I). The multiple sclerosis
subpanel included 42 respondents, 19 of whom were
patients and proxies (45%), and 23 health profes-
sionals (55%). The Parkinson’s disease subpanel
comprised 31 respondents, nine of whom were pa-
tients and proxies (29%), and 22 health professionals
(71%). The neuromuscular diseases sub-panel
consisted of 25 respondents, nine of whom were
patients or proxies (36%) and 16 health professionals
(64%).
The proportion of patients and proxies was dis-
proportionately distributed across the disease panels
with 51% in the Multiple Sclerosis panel. However,
the differences in the proportions of patients and
proxies between the disease panels were not statis-
tically significant (MS vs. PD¼ 16.2%; 95% CI:
75.7 – 38%, MS vs. NMD¼ 9.2%; 95% CI:
715.2 – 33% and PD vs. NMD¼ 7.0%; 95%
CI: 732 – 18%). Furthermore, no statistically sig-
nificant differences in proportions between the strata
of medical and non-medical experts were found
across the disease-specific panels.
Item sampling
First assessment results: No significant differences
were found between the strata ‘patients and proxies’
and ‘health professionals’, or between the disease
subpanels of experts with regard to the sample result
of items belonging to the ICF domains ‘Activities’,
‘Participation’ and ‘Environmental Factors’. In
accordance with the inclusion criteria, the resulting
item samples were merged into one sample com-
prising 46 ‘very relevant’ and 96 ‘relevant’ items
which were then submitted in the second assessment.
Table I. Expert characteristics across panels (n¼ 98).
MS panel PD panel NMD panel Overall panel
Patients and proxies
Patients 17 7 7 31
Proxies 2 2 2 6
Subtotal 19 (51.4) 9 (24.3) 9 (24.3) 37 (100)
(45.2) (29.0) (36.0) (37.8)
Medical experts
Nurse Practitioners 1 1 1 3
Rehabilitation doctors 4 2 2 8
Neurologists 5 4 4 13
General Practitioners – 1 – 1
Nursing home doctors 1 1 – 2
Subtotal 11 (40.7) 9 (33.3) 7 (25.9) 27 (100)
(26.2) (29.0) (28.0) (27.6)
Non-medical experts
Nurses and Nurse specialists 6 6 4 16
Physiotherapists 3 3 2 8
Occupational therapists 2 2 1 5
Welfare workers 1 2 2 5
Subtotal 12 (35.3) 13 (38.2) 9 (26.5) 34 (100)
(28.6) (41.9) (36.0) (34.7)
Total 42 (42.9) 31 (31.6) 25 (25.5) 98 (100)
(100) (100) (100) (100)
Italic percentages across columns.
Bold percentages across rows.
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The selection of ICF items from the ‘Body Functions
and Structures’ domain showed significant differ-
ences between the disease subpanels. According to
the inclusion criteria for the initial sample, the
number of body functions items as well as the
content of selected items differed, with Multiple
Sclerosis having 39 items, Parkinson’s disease 29
items and neuromuscular diseases 28 items. It was
therefore decided not to merge the ‘Body Function
and Structures’ item samples from the disease
subpanels. Each subpanel was requested to appraise
the disease-specific outcome of the first assessment
for this domain within the second assessment.
Second assessment results: According to the
criterion of the content validity index, at least 80%
of the complete panel had to agree with the inclusion
of an item in the domains ‘Activities’, ‘Participation’
and ‘Environmental Factors’. Two items were there-
fore removed from the first selection of ‘very relevant’
items, and two items from the selection of ‘relevant’
items were added to the ‘very relevant’ items. For the
‘Body Functions and Structures’ domain the criteria
for selection were broadened in order to achieve con-
sensus on a representative sample of items: an item
was selected in the final sample when 80% agreed with
inclusion of an item in one or more subpanels rather
than in each of the three subpanels.
Finally, 68 ‘very relevant’ items, belonging to the
four domains of the ICF, were selected: Body
Functions and Structures (20 items); Activities (21
items), Participation (17 items) and Environmental
Factors (10 items).
Interrater agreement
The agreement indexes (D) for the final selected
items were calculated. The results in Table II show a
large amount of agreement (range between 0 and
þ1) across the disease subpanels and in the overall
panel.
Convergent validity
The 31 items belonging to the MRD and the 40
items belonging to the DIP were linked to the
selected ICF items as shown in Tables III – VI. Gen-
erally, one item from the convergent measure was
linked to one item of the ICF selection, indicated by
a ‘1’ in the table. A higher number in the table
indicates that an item of the health status measure
addressed the same ICF item, or that the selected
ICF item did not differentiate in greater detail, and
therefore several items from the measure had to be
linked to the same ICF item. For example the MRD
items ‘Cerebral (or) mental functions’ (FS 7),
‘Mentation’ (ISS 13) and ‘Mood and Thought’
(ISS 14) had to be linked to the same ICF item
‘Thought functions’ (b160). Newly selected ICF
items by the panel that were not addressed by the
measure’s items are indicated by a dash (–) in the
tables.
Disease-specific convergent validity: The ICF
item selection includes almost all items belonging
to the disease-specific measure for Multiple Sclero-
sis, the MRD, except for three not definable items:
‘Hearing’, ‘Stair climbing’ and ‘Medical problems’.
However, 27 items are newly selected in this study
in comparison to the MRD items, as shown in
Tables III – VI. The panel selected the items ‘Sleep
functions’, ‘Attention functions’, and ‘Exercise
tolerance’ belonging to the ‘Body Functions and
Structures domain’. Eight new items were selected
comprising the ‘Activities’ domain concerning ‘com-
munication’ (two items), ‘mobility’ (two items), ‘self
care’ (two items) and ‘domestic life’ (two items). The
greatest contrast was reflected by the results of the
item selection regarding the ‘Participation’ and
‘Environmental Factors’ domains: all MRD items
are covered by the sample of ICF items, but the ICF
panel selected 16 items that do not belong to the
MRD. For the participation domain these items
concerned participation in ‘communication’ (two
items), ‘mobility’ (two items), ‘self care’ (five items)
and ‘domestic life’ (one item). Items selected from
the Environmental Factors domain concerned ‘pro-
ducts and technology’ (four items), ‘support and
relationships’ (one item) and ‘services, systems and
policies’ (one item).
Generic convergent validity: The ICF item selec-
tion covers almost all items of the DIP except for six
not definable items concerning ‘visible deformities’,
‘stand’, ‘climb stairs’, ‘hear’, ‘determine day pro-
gram’ and ‘reach goal in life’. Thirty-two items have
been newly selected in this study. The panel selected
five items for ‘muscle and movement functions’ for
the ‘Body Functions and Structures’ domain. The
panel selected seven more items for the ‘Activities’
domain concerning ‘communication’ (two items),
‘mobility’ and ‘self care’ (three items). The largest
contrast was shown in the item selection for the
‘Participation’ and ‘Environmental Factors’ do-
mains: all items in the DIP are covered, but the
panel selected 18 items which do not appear in the
DIP. These concerned items about participation in
‘communication’ (two items), ‘mobility’ (one item),
‘self-care’ (five items) and ‘community’ (one item)
and all 10 selected items in the ‘Environmental
Factors’ domain with the exception of the ‘social
security services’ item.
Discussion
The main challenge in this study was to develop a
comprehensive yet concise set of items covering the
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Table II. Median scores on item relevance and the interrater agreement index (D) for the final selected ICF items within the disease sub-










Median D Median D Median D Median D
Body functions
Energy level 4 0.21 4 0.50 4 0.67 4 0.44
Sleep functions 3 0.40 4 0.34 3 0.87 3 0.53
Attention functions 3 0.78 3 0.60 3 0.79 3 0.70
Memory functions 3 0.60 3 0.90 3 0.85 3 0.78
Emotional functions 4 0.50 3 0.78 4 0.67 4 0.66
Thought functions 3 0.90 4 0.40 3 0.83 3 0.73
Seeing functions 4 0.50 3 0.70 3 0.55 3 0.59
Sensation of pain 4 0.40 4 0.70 4 0.25 4 0.41
Articulation functions 4 0.20 3 0.75 3 0.89 3 0.63
Exercise tolerance 4 0.40 4 0.30 4 0.27 4 0.31
Swallowing 3 0.55 3 0.20 3 0.36 3 0.37
Defecation functions 4 0.30 3 0.80 3 0.78 3 0.63
Urinary functions 4 0.20 3 0.77 4 0.58 3 0.51
Muscle power functions 4 0.50 4 0.40 4 0.23 4 0.39
Control of voluntary movements 4 0.50 4 0.60 4 0.41 4 0.52
Involuntary movements 4 0.40 4 0.20 3 0.38 3 0.31
Gait pattern functions 4 0.60 4 0.50 3 0.88 3 0.64
Sensations related to muscle and movements 3 0.71 4 0.47 4 0.25 3 0.45
Activities
Speaking 3 0.90 3 0.83 3 0.95 3 0.89
Conversation 3 0.82 4 0.59 3 0.81 3 0.82
Using communication devices 3 0.62 3 0.67 3 0.74 3 0.67
Maintaining a body position 4 0.57 4 0.50 4 0.64 4 0.61
Changing basic body position 4 0.61 4 0.47 4 0.77 4 0.63
Transferring oneself 4 0.45 4 0.37 4 0.71 4 0.48
Fine hand use 4 0.65 4 0.43 4 0.50 4 0.54
Hand and arm use 4 0.55 3 0.53 4 0.77 4 0.61
Walking 4 0.45 4 0.10 4 0.50 4 0.35
Moving around using equipment 4 0.55 3 0.76 4 0.14 4 0.54
Using transportation as a passenger 4 0.54 4 0.82 3 0.86 4 0.73
Washing and drying oneself 4 0.45 4 0.37 4 0.38 4 0.40
Caring for body parts 4 0.50 4 0.30 4 0.54 4 0.44
Toiletting 4 0.35 4 0.37 4 0.40 4 0.36
Dressing 4 0.40 4 0.57 4 0.68 4 0.55
Eating 4 0.57 4 0.37 4 0.68 4 0.53
Drinking 4 0.65 4 0.40 4 0.45 4 0.52
Looking after one’s health 3 0.85 4 0.50 4 0.81 4 0.75
Preparing meals 3 0.70 3 0.73 3 0.57 3 0.68
Doing housework 3 0.87 3 0.73 3 0.77 3 0.80
Engaging in physical intimacy 3 0.82 3 0.65 3 0.77 3 0.75
Recreation and leisure 3 0.66 3 0.57 3 0.64 3 0.62
Participation
In personal care 4 0.32 4 0.42 4 0.71 4 0.45
In preparing meals 3 0.74 4 0.54 3 0.79 3 0.74
In mobility within the home 4 0.59 4 0.61 3 0.79 4 0.71
In mobility within buildings other than the home 4 0.19 4 0.19 4 0.33 4 0.23
In mobility outside the home and other buildings 4 0.31 4 0.29 4 0.54 4 0.36
In using transportation 4 0.31 4 0.33 4 0.37 4 0.33
In conversation 4 0.36 4 0.45 4 0.25 4 0.36
In using communication devices 4 0.53 4 0.54 3 0.75 4 0.46
In family relationships 4 0.32 3 0.40 4 0.67 3 0.41
In intimate relationships 4 0.47 4 0.58 4 0.91 4 0.61
In informal social relationships 4 0.36 4 0.45 3 0.86 4 0.50
In acquiring a place to live 3 0.64 3 0.45 3 0.62 3 0.57
In remunerative employment 4 0.48 3 0.42 4 0.87 3 0.67
In community life 4 0.66 3 0.79 4 0.83 3 0.81
In recreation and leisure 4 0.62 4 0.61 3 0.65 4 0.65
(continued)
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wide spectrum of health problems for people with
Multiple Sclerosis, Parkinson’s disease and neuro-
muscular diseases. A Delphi study performed by
98 experts resulted in a representative sample of
68 clinically relevant items for these groups of
chronically ill persons selected from the four ICF
domains.
The study was explicitly aimed at including the
experience of patients and proxies, but also from dif-
ferent professions contributing to a patient-centred
item selection. This is why 38% of the panel mem-











Median D Median D Median D Median D
External factors
Prod. and techn. for personal use in daily living 4 0.51 4 0.67 4 0.82 4 0.64
Prod. and techn. for communication 4 0.67 3 0.68 4 0.56 3 0.72
Prod. and techn. for mobility and transportation 4 0.25 4 0.64 4 0.26 4 0.38
Immediate family 4 0.42 4 0.48 4 0.58 4 0.48
Personal care providers and personal assistants 3 0.65 3 0.83 4 0.73 3 0.76
Transportation services 4 0.57 3 0.96 3 0.75 3 0.78
Social security services 4 0.33 4 0.74 4 0.61 4 0.52
Social security policies 4 0.64 4 0.64 4 0.54 4 0.61
Health services, systems and policies 4 0.38 4 0.35 4 0.21 4 0.32
D, index for interrater agreement: mean deviation from the median.
Table III. The number of items belonging to the ICF domain
‘Body functions and structures’ associated with MRD and DIP
items.
ICF code ICF label MRD DIP
Mental functions
B1300 Energy level 1 1
B134 Sleep functions – 1
B140 Attention functions – 1
B144 Memory functions 2 1
B152 Emotional functions 3 2
B160 Thought functions 3 –
Sensory functions and pain
B210 Seeing functions 3 2
B280 Sensation of pain 1 1
Voice and speech functions
B320 Articulation functions 2 1
Functions of cardiovascular and
respiratory systems
B455 Exercise tolerance functions – 1
Ingestion functions
B5105 Swallowing 1 –
B525 Defecation functions 2 1
Genitourinary and reproductive functions
B620 Urination functions 2 1
B640 Sexual functions 1 1
Muscle and movement functions
B730 Muscle power functions 1 1
B735 Muscle tone functions 2 –
B760 Control of voluntary movement
functions
1 –
B765 Involuntary movements functions 1 –
B770 Gait pattern functions 4 –
B780 Sensations related to muscle and
movement functions
1 –
Table IV. The number of items belonging to the ICF domain
‘Activities’ associated with MRD and DIP items.
ICF code ICF label MRD DIP
Communication
A330 Speaking 1 1
A350 Conversation – –




A410 Changing basic body position 1 1
A415 Maintaining a body position 1 –
A420 Transferring oneself 1 1
A440 Fine hand use – 1
A445 Hand and arm use – 2
A450 Walking 1 1
A465 Moving around using equipment 1 –
A470 Using transportation 1 1
Self-care
A510 Washing oneself 1 1
A520 Caring for body parts 1 –
A530 Toileting 2 1
A540 Dressing 1 1
A550 Eating 1 1
A560 Drinking – –
A570 Looking after ones health – –
Domestic life
A630 Preparing meals – 1
A640 Doing housework – 1
Community, social and civic life
A920 Recreation and leisure 1 1
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consisted of health professionals from medical and
non-medical health disciplines.
Analyses did not show any significant differences
between the ‘patients and proxies’ and both ‘health
professionals’ strata. This may indicate that health-
care professionals have a valid and accurate view of
the consequences of neurological diseases within all
ICF domains. It may also indicate that patients
judged the relevance of items with a generic view
beyond their personal situation.
A positive conclusion could be drawn about the
evaluation of the disease-specific and the generic
convergent validity of the final ICF item set. It
became clear that almost all items, except for three
items in the MRD and six items in the DIP, were
covered by the selected ICF items while 27,
respectively, 32 items were added with the ICF
selection. The greatest contrast with these measures
was found for the ‘Participation’ and ‘Environmental
Factors’ domains. Applying this broader item selec-
tion to clinical practice and research might generate
useful information.
The Delphi method, as applied in this study,
proved to be a reliable way to select items from a large
sample. Because we used questionnaires, it was
possible to invite a broad and varied panel of experts
from The Netherlands and Belgium to participate.
Panel members did not need to travel and could
answer the questions at any chosen moment. Al-
though participation in the panel required substantial
input by panel members, the drop out during the
research was low and commitment was high. Another
advantage of this written method is that information
bias may have been avoided since persuasive or
prestigious experts cannot have had an undue influ-
ence on the opinions of others, as could happen in a
face-to-face situation during, for example consensus
conferences [12]. The interrater agreement index D
was developed in order to confirm the results from
the content validity index. This new index provided a
more accurate picture of the amount of consensus in
the disease subpanels and in the overall panel.
According to Raine et al. [35] we included this index
of the strength of support and extent of agreement
about each recommendation.
Merging items for the three disease subpanels
caused no problem for the ICF domains ‘Activities’,
‘Participation’ and ‘Environmental Factors’. This
supported the assumption that consequences of
chronic neurological diseases are similar, despite the
differences in impairments caused by the disease. The
consensus between the subpanels about the ‘Body
Functions and Structures’ items, however, was more
complicated. This finding supports the suggestion
that disease-specific applications in the measurement
of the body impairment items are indicated.
The ICF proved to be a useful classification for
selecting items. No items were missed, although
some panel members mentioned missing terms to
cover patients’ experiences and coping styles. Al-
though the ICF language was experienced as formal
Table V. The number of items belonging to the ICF domain
‘Participation’ associated with MRD and DIP items.
ICF code ICF label MRD DIP
Communication
P350 Conversation – –




P460 Moving around in different locations – –
P470 Using transportation – 1
Self-care
P510 Washing oneself – –
P520 Caring for body parts – –
P530 Toileting – –
P540 Dressing – –
P570 Looking after one’s health – –
Domestic life
P610 Acquiring a place to live 1 1
P630 Preparing meals – 1
Interpersonal interactions and
relationships
P750 Informal social relationships 1 1
P760 Family relationships 1 1
P770 Intimate relationships 1 1
Major life areas
P850 Remunerative employment 1 1
Community, social and civic life
P910 Community life 2 –
P920 Recreation and leisure 1 1
Table VI. The number of items belonging to the ICF domain
‘Environmental factors’ associated with MRD and DIP items.
ICF code ICF label MRD DIP
Products and technology
E115 Products and technology for personal
use in daily living
– –
E120 Products and technology for indoor
and outdoor mobility and
transportation
– –
E125 Products and technology for
communication
– –
E155 Design, construction and building
products and technology of
buildings for private use
– –
Support and relationships
E310 Immediate family – –
E340 Personal care providers and personal
assistants
2 –
Services, systems and policies
E5400 Transportation services – –
E5700 Social security services 1 1
E5702 Social security policies 1 –
E580 Health services, systems and policies 1 –
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and sometimes difficult to understand, it turned out
to be useful in an interdisciplinary setting: no mis-
understanding of items arose.
The full version of the ICF with items on the third
and fourth more detailed levels was initially presented
to the panel in order to avoid selection bias. During
the Delphi study, the decision was made to include
items in the selection only at the third level of detail to
reduce the number of selected items to a manageable
number. This was assumed to be a safe decision for
two reasons: (1) the goal of this study was to select
items indicating problem areas, so detailed informa-
tion was less relevant, and (2) for all issues except two
the subpanels selected items on the third as well as
the fourth level of detail, so no relevant items were
excluded by this decision. Van Achterberg et al. [36]
and Sykes et al. [37] also found a substantial
preference for using items of the third level of detail
in assessment tools. In a future item selection study
with the same goal, it might be advisable to present
only items from the third level of detail.
Compared with the substantial contribution and
meaningful outcomes of the ICF Core Sets project
[11] this study differed at three points. Firstly,
patients and proxies were given a significant role in
the item selection process, where the ICF Core Sets
project needs a separate procedure for validating the
ICF Core Set with patients [38]. Secondly, the
application of Consensus Conferences in the ICF
Core Sets project has the disadvantage of a risk of ‘any
one persuasive or prestigious expert having an undue
influence on the opinions of others’ [12]. In this study
a written Delphi method was applied so each panel
member was on equal footing with all others. Thirdly,
in contrast with the procedures of the ICF Core Sets
project, no literature review was performed to make a
selection of items. A literature review was considered
but not performed to avoid selection bias and to give
each item an equal chance to be selected.
This study has some potential limitations. One
limitation relates to the selection of experts. All
experts came from The Netherlands and Belgium so
results obtained in this study cannot be generalized
to other countries without validation studies in other
regions.
This study was conducted during the ICIDH-ICF
revision process. In the first phase of the study the
‘ICIDH-2 beta-2 draft’ [39] was the most recent
version of the Classification and was therefore used.
The final draft was released in May 2001 and named
‘International Classification of Functioning, Disabil-
ity and Health’ [10]. After finishing this study we
decided to recode the selected ICIDH-2 items and
codes into the new ICF items and codes. Each
ICIDH-2 item was linked to a corresponding ICF
item. An important change in the ICF is the
integration of the ‘Activities’ and ‘Participation’
domains into a single list. In this study the distinction
between ‘Activities’ and ‘Participation’ was main-
tained with respect to the selection made by the
panel. Although the recoding procedure was carried
out meticulously by three independent experts on the
ICIDH-2 and ICF, in the case we used the same set
of items in the ICF structure and the wording of the
experts’ appraisal may have deviated from the out-
comes of the current study.
In conclusion, selected items for persons with a
chronic neurological disease covered a broader scope
of health problems compared with existing instru-
ments, especially for the ‘Participation’ and ‘Envi-
ronmental Factors’ domains. The scope of research
and clinical practice for chronic neurological dis-
orders should be widened.
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